In another study, Gault et al. [37] showed that GLP-1 receptor agonist therapy improved cognitive function and ameliorated impaired hippocampal synaptic plasticity in dietary-induced obesity. This evidence concerns the gene GLP1R and obesity due to melanocortin 4 receptor deficiency.